<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <version>2.0</version>
  <creation_date>2012-08-09 09:16:15 -0600</creation_date>
  <update_date>2015-10-15 16:13:53 -0600</update_date>
  <accession>ECMDB21438</accession>
  <m2m_id>M2MDB001833</m2m_id>
  <name>Ubiquinone-1</name>
  <description>Ubiquinone-1 is a member of the chemical class known as Polyprenylbenzoquinones. These are compounds containing a polyisoprene chain attached to a quinone at the second ring position. Ubiquione-1 has just 1 isoprene unit. Normally in E. coli the active form of Ubiquinone has 8 isoprene units (Ubiquinone-8) and in humans it normally has 10. Ubiquinone-1 is a “failed” or incomplete version of Ubiquinone 8 that arises from conjugation by a shortened prenyl tail via 4-hydroxybenzoate polyprenyltransferase. Ubiquionone is involved in cellular respiration. It is fat-soluble and is therefore mobile in cellular membranes; it plays a unique role in the electron transport chain (ETC). In the inner bacterial membrane, electrons from NADH and succinate pass through the ETC to the oxygen, which is then reduced to water. The transfer of electrons through ETC results in the pumping of H+ across the membrane creating a proton gradient across the membrane, which is used by ATP synthase (located on the membrane) to generate ATP.</description>
  <synonyms>
    <synonym>2,3-dimethoxy-5-methyl-6-(3-methylbut-2-enyl)cyclohexa-2,5-diene-1,4-dione</synonym>
    <synonym>A ubiquinone</synonym>
    <synonym>Coenzym Q</synonym>
    <synonym>coenzyme Q</synonym>
    <synonym>Coenzyme Q1</synonym>
    <synonym>Coenzymes Q</synonym>
    <synonym>CoQ</synonym>
    <synonym>CoQ1</synonym>
    <synonym>Koenzym Q</synonym>
    <synonym>Mitoquinones</synonym>
    <synonym>Q</synonym>
    <synonym>Q1</synonym>
    <synonym>Ubichinon</synonym>
    <synonym>Ubiquinone</synonym>
    <synonym>Ubiquinone 5</synonym>
    <synonym>Ubiquinone Q1</synonym>
    <synonym>Ubiquinone(1)</synonym>
    <synonym>Ubiquinone-Q1</synonym>
    <synonym>Ubiquinones</synonym>
    <synonym>Ubiquionone 1</synonym>
  </synonyms>
  <chemical_formula>C19H28O4</chemical_formula>
  <average_molecular_weight>320.429</average_molecular_weight>
  <monisotopic_moleculate_weight>320.198759382</monisotopic_moleculate_weight>
  <iupac_name>2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione</iupac_name>
  <traditional_iupac>ubiquinone-1</traditional_iupac>
  <cas_registry_number>727-81-1</cas_registry_number>
  <smiles>COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)C)C(O)=C1OC</smiles>
  <inchi>InChI=1S/C19H28O4/c1-12(2)8-7-9-13(3)10-11-15-14(4)16(20)18(22-5)19(23-6)17(15)21/h8,10,20-21H,7,9,11H2,1-6H3</inchi>
  <inchikey>RNUCUWWMTTWKAH-UHFFFAOYSA-N</inchikey>
  <state>Solid</state>
  <cellular_locations>
    <cellular_location>Membrane</cellular_location>
  </cellular_locations>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>2.20</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>-3.02</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>2.39e-01 g/l</value>
      <source>ALOGPS</source>
    </property>
  </predicted_properties>
  <experimental_properties>
  </experimental_properties>
  <property>
    <kind>logp</kind>
    <value>2.22</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>pka_strongest_basic</kind>
    <value>-4.7</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>iupac</kind>
    <value>2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>average_mass</kind>
    <value>320.429</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>mono_mass</kind>
    <value>320.198759382</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>smiles</kind>
    <value>COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)C)C(O)=C1OC</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>formula</kind>
    <value>C19H28O4</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>inchi</kind>
    <value>InChI=1S/C19H28O4/c1-12(2)8-7-9-13(3)10-11-15-14(4)16(20)18(22-5)19(23-6)17(15)21/h8,10,20-21H,7,9,11H2,1-6H3</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>inchikey</kind>
    <value>RNUCUWWMTTWKAH-UHFFFAOYSA-N</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>polar_surface_area</kind>
    <value>52.6</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>refractivity</kind>
    <value>72.38</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>polarizability</kind>
    <value>26.94</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>rotatable_bond_count</kind>
    <value>4</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>acceptor_count</kind>
    <value>4</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>donor_count</kind>
    <value>0</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>physiological_charge</kind>
    <value>0</value>
    <source>ChemAxon</source>
  </property>
  <property>
    <kind>formal_charge</kind>
    <value>0</value>
    <source>ChemAxon</source>
  </property>
  <pathways>
    <pathway>
      <name>Pentose phosphate pathway</name>
      <description/>
      <pathwhiz_id/>
      <kegg_map_id>ec00030</kegg_map_id>
      <subject/>
    </pathway>
    <pathway>
      <name>Oxidative phosphorylation</name>
      <description>The process of oxidative phosphorylation involves multiple interactions of ubiquinone with succinic acid, resulting in a fumaric acid and ubiquinol.

Ubiquinone interacts with succinic acid through a succinate:quinone oxidoreductase resulting in a fumaric acid an ubiquinol. This enzyme has various cofactors, ferroheme b, 2FE-2S, FAD, and 3Fe-4S iron-sulfur cluster. 
Then 2 ubiquinol interact with oxygen and 4 hydrogen ion through a cytochrome bd-I terminal oxidase resulting in a 4 hydrogen ion transferred into the periplasmic space, 2  water returned into the cytoplasm and 2 ubiquinone, which stay in the inner membrane.
The ubiquinone interacts with succinic acid through a succinate:quinone oxidoreductase resulting in a fumaric acid an ubiquinol. 
Then 2 ubiquinol interacts with oxygen and 4 hydrogen ion through a cytochrome bd-II terminal oxidase resulting in a 4 hydrogen ion transferred into the periplasmic space, 2 water returned into the cytoplasm and 2 ubiquinone, which stay in the inner membrane.
The ubiquinone interacts with succinic acid through a succinate:quinone oxidoreductase resulting in a fumaric acid an ubiquinol. 
The 2 ubiquinol interact with oxygen and 8 hydrogen ion through a cytochrome bo terminal oxidase resulting in a 8 hydrogen ion transferred into the periplasmic space, 2 water returned into the cytoplasm and 2 ubiquinone, which stays in the inner membrane.
The ubiquinone then interacts with 5 hydrogen ion through a NADH dependent ubiquinone oxidoreductase I resulting in NAD, hydrogen ion released into the periplasmic space and an ubiquinol.
 The ubiquinol is then processed reacting with oxygen, and 4 hydrogen through a ion cytochrome bd-I terminal oxidase resulting in 4 hydrogen ions released into the periplasmic space, 2 water molecules into the cytoplasm and 2 ubiquinones.
The ubiquinone then interacts with 5 hydrogen ion through a NADH dependent ubiquinone oxidoreductase I resulting in NAD, hydrogen ion released into the periplasmic space and an ubiquinol.
The 2 ubiquinol interact with oxygen and 8 hydrogen ion through a cytochrome bo terminal oxidase resulting in a 8 hydrogen ion transferred into the periplasmic space, 2 water returned into the cytoplasm and 2 ubiquinone, which stays in the inner membrane.
</description>
      <pathwhiz_id>PW000919</pathwhiz_id>
      <kegg_map_id>ec00190</kegg_map_id>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>Pyrimidine metabolism</name>
      <description>The metabolism of pyrimidines begins with L-glutamine interacting with water molecule and a hydrogen carbonate through an ATP driven carbamoyl phosphate synthetase resulting in a hydrogen ion, an ADP, a phosphate, an L-glutamic acid and a carbamoyl phosphate. The latter compound interacts with an L-aspartic acid through a aspartate transcarbamylase resulting in a phosphate, a hydrogen ion and a N-carbamoyl-L-aspartate. The latter compound interacts with a hydrogen ion through a dihydroorotase resulting in the release of a water molecule and a 4,5-dihydroorotic acid. This compound interacts with an ubiquinone-1 through a dihydroorotate dehydrogenase, type 2 resulting in a release of an ubiquinol-1 and an orotic acid. The orotic acid then interacts with a phosphoribosyl pyrophosphate through a orotate phosphoribosyltransferase resulting in a pyrophosphate and an orotidylic acid. The latter compound then interacts with a hydrogen ion through an orotidine-5 '-phosphate decarboxylase, resulting in an release of carbon dioxide and an Uridine 5' monophosphate. The Uridine 5' monophosphate process to get phosphorylated by an ATP driven UMP kinase resulting in the release of an ADP and an Uridine 5--diphosphate.
Uridine 5-diphosphate can be metabolized in multiple ways in order to produce a Deoxyuridine triphosphate.
        1.-Uridine 5-diphosphate interacts with a reduced thioredoxin through a ribonucleoside diphosphate reductase 1 resulting in the release of a water molecule and an oxidized thioredoxin and an dUDP. The dUDP is then phosphorylated by an ATP through a nucleoside diphosphate kinase resulting in the release of an ADP and a DeoxyUridine triphosphate.
        2.-Uridine 5-diphosphate interacts with a reduced NrdH glutaredoxin-like protein through a Ribonucleoside-diphosphate reductase 1 resulting in a release of a water molecule, an oxidized NrdH glutaredoxin-like protein and a dUDP. The dUDP is then phosphorylated by an ATP through a nucleoside diphosphate kinase resulting in the release of an ADP and a DeoxyUridine triphosphate.
        3.-Uridine 5-diphosphate is phosphorylated by an ATP-driven nucleoside diphosphate kinase resulting in an ADP and an Uridinetriphosphate. The latter compound interacts with a reduced flavodoxin through ribonucleoside-triphosphate reductase resulting in the release of an oxidized flavodoxin, a water molecule and a Deoxyuridine triphosphate
        4.-Uridine 5-diphosphate is phosphorylated by an ATP-driven nucleoside diphosphate kinase resulting in an ADP and an Uridinetriphosphate    The uridine triphosphate interacts with a L-glutamine and a water molecule through an ATP driven CTP synthase resulting in an ADP, a phosphate, a hydrogen ion, an L-glutamic acid and a cytidine triphosphate. The cytidine triphosphate interacts with a reduced flavodoxin through a ribonucleoside-triphosphate reductase resulting in the release of a water molecule, an oxidized flavodoxin and a dCTP. The dCTP interacts with a water molecule and a hydrogen ion through a dCTP deaminase resulting in a release of an ammonium molecule and a Deoxyuridine triphosphate.
        5.-Uridine 5-diphosphate is phosphorylated by an ATP-driven nucleoside diphosphate kinase resulting in an ADP and an Uridinetriphosphate The uridine triphosphate interacts with a L-glutamine and a water molecule through an ATP driven CTP synthase resulting in an ADP, a phosphate, a hydrogen ion, an L-glutamic acid and a cytidine triphosphate. The cytidine triphosphate then interacts spontaneously with a water molecule resulting in the release of a phosphate, a hydrogen ion and a CDP. The CDP then interacts with a reduced NrdH glutaredoxin-like protein through a ribonucleoside-diphosphate reductase 2 resulting in the release of a water molecule, an oxidized NrdH glutaredoxin-like protein and a dCDP. The dCDP is then phosphorylated through an ATP driven nucleoside diphosphate kinase resulting in an ADP and a dCTP. The dCTP interacts with a water molecule and a hydrogen ion through a dCTP deaminase resulting in a release of an ammonium molecule and a Deoxyuridine triphosphate.
        6.-Uridine 5-diphosphate is phosphorylated by an ATP-driven nucleoside diphosphate kinase resulting in an ADP and an Uridinetriphosphate The uridine triphosphate interacts with a L-glutamine and a water molecule through an ATP driven CTP synthase resulting in an ADP, a phosphate, a hydrogen ion, an L-glutamic acid and a cytidine triphosphate. The cytidine triphosphate then interacts spontaneously with a water molecule resulting in the release of a phosphate, a hydrogen ion and a CDP. The CDP interacts with a reduced thioredoxin through a ribonucleoside diphosphate reductase 1 resulting in a release of a water molecule, an oxidized thioredoxin and a dCDP. The dCDP is then phosphorylated through an ATP driven nucleoside diphosphate kinase resulting in an ADP and a dCTP. The dCTP interacts with a water molecule and a hydrogen ion through a dCTP deaminase resulting in a release of an ammonium molecule and a Deoxyuridine triphosphate.

The deoxyuridine triphosphate then interacts with a water molecule through a nucleoside triphosphate pyrophosphohydrolase resulting in a release of a hydrogen ion, a phosphate and a dUMP. The dUMP then interacts with a methenyltetrahydrofolate through a thymidylate synthase resulting in a dihydrofolic acid and a 5-thymidylic acid. Then 5-thymidylic acid is then phosphorylated through a nucleoside diphosphate kinase resulting in the release of an ADP and thymidine 5'-triphosphate.</description>
      <pathwhiz_id>PW000942</pathwhiz_id>
      <kegg_map_id>ec00240</kegg_map_id>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>TCA cycle</name>
      <description>
The TCA pathway is a catabolic pathway of aerobic respiration. It generates energy and reducing power. It is the first step in generating precursors for biosynthesis. When acetate is the carbon source, citrate synthase is rate-limiting for the TCA cycle. Respiration is an ATP-generating process in which compounds act as electron donors through a chain of electron transfer to electron acceptors. Aerobic respiration uses oxygen as the final acceptor. Anaerobic respiration uses several organic compounds as acceptors such as fumarate, nitrate and hydrogen. During the chain of electron transfer, protons (H+) are transported outside the cytoplasmic membrane, generating a proton motive force. Upon passage of protons back into the cytoplasm, the PMF energy is captured as ATP, catalyzed by a multisubunit ATPase.
The cycle can start from Acetyl-CoA interacting with Oxalacetic acid and water through a citrate synthase monomer resulting in a hydrogen ion, CoA and a Citric Acid. The latter compound is dehydrated by a Citrate hydro-lyase resulting in the release of water and a cis-Aconitic acid. This compound is then hydrated through a Citrate hydro-lyase resulting in a D-threo-Isocitric acid. This compound is decarboxylated by an NADP dependent Citrate dehydrogenase, resulting in a release of carbon dioxide and NADPH and Oxoglutaric acid. The oxoglutaric acid interacts with a Coenzyme A through a NAD driven 2-oxoglutarate dehydrogenase resulting in a release of carbon dioxide, an NADH and succinyl-CoA. The succinyl-CoA interacts with a phosphate and an ADP through a 2-oxoglutarate dehydrogenase resulting in a CoA, an ATP and Succinic Acid. Succinic acid interacts with a ubiquinone, in this case a ubiquinone 1 through a succinate:quinone oxidoreductase resulting in an ubiquinol, in this case a ubiquinol-1 and a fumaric acid.
The fumaric acid interacts with water through a fumarase hydratase resulting in a L-Malic acid.This compound can either interact with quinone through a malate:quinone oxidoreductase resulting in a release of hydroquinone and oxalacetic acid, or it can react with an NAD through a malate dehydrogenase resulting in a hydrogen ion, NADH and Oxalacetic acid.</description>
      <pathwhiz_id>PW000779</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>glycerol metabolism</name>
      <description>Glycerol metabolism  starts with glycerol is introduced into the cytoplasm through a glycerol channel GlpF Glycerol is then phosphorylated through an ATP mediated glycerol kinase resulting in a Glycerol 3-phosphate. This compound can also be obtained through a glycerophosphodiester reacting with water through a glycerophosphoryl diester phosphodiesterase or it can also be introduced into the cytoplasm through a glycerol-3-phosphate:phosphate antiporter. 
Glycerol 3-phosphate is then metabolized into a dihydroxyacetone phosphate in both aerobic or anaerobic conditions. In anaerobic conditions the metabolism is done through the reaction of glycerol 3-phosphate with a menaquinone mediated by a glycerol-3-phosphate dehydrogenase protein complex. In aerobic conditions, the metabolism is done through the reaction of glycerol 3-phosphate with ubiquinone mediated by a  glycerol-3-phosphate dehydrogenase [NAD(P]+].
Dihydroxyacetone phosphate is then introduced into the fructose metabolism by turning a dihydroxyacetone into an isomer through a triosephosphate isomerase resulting in a D-glyceraldehyde 3-phosphate which in turn reacts with a phosphate through a NAD dependent Glyceraldehyde 3-phosphate dehydrogenase resulting in a glyceric acid 1,3-biphosphate. This compound is desphosphorylated by a phosphoglycerate kinase resulting in a 3-phosphoglyceric acid.This compound in turn can either react with a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase or a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase resulting in a 2-phospho-D-glyceric acid. This compound interacts with an enolase resulting in a phosphoenolpyruvic acid and water. Phosphoenolpyruvic acid can react either through a AMP driven phosphoenoylpyruvate synthase or a ADP driven pyruvate kinase protein complex resulting in a pyruvic acid. Pyruvic acid reacts with CoA through a NAD driven pyruvate dehydrogenase complex resulting in a carbon dioxide and a Acetyl-CoA which gets incorporated into the TCA cycle pathway.</description>
      <pathwhiz_id>PW000914</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>glycerol metabolism II</name>
      <description>Glycerol metabolism starts with glycerol is introduced into the cytoplasm through a glycerol channel GlpF Glycerol is then phosphorylated through an ATP mediated glycerol kinase resulting in a Glycerol 3-phosphate. This compound can also be obtained through sn-glycero-3-phosphocholine reacting with water through a glycerophosphoryl diester phosphodiesterase  producing a benzyl alcohol, a hydrogen ion and a glycerol 3-phosphate or  the campound can be introduced into the cytoplasm through a glycerol-3-phosphate:phosphate antiporter. Glycerol 3-phosphate is then metabolized into a dihydroxyacetone phosphate in both aerobic or anaerobic conditions. In anaerobic conditions the metabolism is done through the reaction of glycerol 3-phosphate with a menaquinone mediated by a glycerol-3-phosphate dehydrogenase protein complex. In aerobic conditions, the metabolism is done through the reaction of glycerol 3-phosphate with ubiquinone mediated by a glycerol-3-phosphate dehydrogenase [NAD(P]+]. Dihydroxyacetone phosphate is then introduced into the fructose metabolism by turning a dihydroxyacetone into an isomer through a triosephosphate isomerase resulting in a D-glyceraldehyde 3-phosphate which in turn reacts with a phosphate through a NAD dependent Glyceraldehyde 3-phosphate dehydrogenase resulting in a glyceric acid 1,3-biphosphate. This compound is desphosphorylated by a phosphoglycerate kinase resulting in a 3-phosphoglyceric acid.This compound in turn can either react with a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase or a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase resulting in a 2-phospho-D-glyceric acid. This compound interacts with an enolase resulting in a phosphoenolpyruvic acid and water. Phosphoenolpyruvic acid can react either through a AMP driven phosphoenoylpyruvate synthase or a ADP driven pyruvate kinase protein complex resulting in a pyruvic acid. Pyruvic acid reacts with CoA through a NAD driven pyruvate dehydrogenase complex resulting in a carbon dioxide and a Acetyl-CoA which gets incorporated into the TCA cycle pathway.</description>
      <pathwhiz_id>PW000915</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>glycerol metabolism III (sn-glycero-3-phosphoethanolamine)</name>
      <description>Glycerol metabolism starts with glycerol is introduced into the cytoplasm through a glycerol channel GlpF Glycerol is then phosphorylated through an ATP mediated glycerol kinase resulting in a Glycerol 3-phosphate. This compound can also be obtained through sn-glycero-3-phosphethanolamine reacting with water through a glycerophosphoryl diester phosphodiesterase producing a benzyl alcohol, a hydrogen ion and a glycerol 3-phosphate or the campound can be introduced into the cytoplasm through a glycerol-3-phosphate:phosphate antiporter. Glycerol 3-phosphate is then metabolized into a dihydroxyacetone phosphate in both aerobic or anaerobic conditions. In anaerobic conditions the metabolism is done through the reaction of glycerol 3-phosphate with a menaquinone mediated by a glycerol-3-phosphate dehydrogenase protein complex. In aerobic conditions, the metabolism is done through the reaction of glycerol 3-phosphate with ubiquinone mediated by a glycerol-3-phosphate dehydrogenase [NAD(P]+]. Dihydroxyacetone phosphate is then introduced into the fructose metabolism by turning a dihydroxyacetone into an isomer through a triosephosphate isomerase resulting in a D-glyceraldehyde 3-phosphate which in turn reacts with a phosphate through a NAD dependent Glyceraldehyde 3-phosphate dehydrogenase resulting in a glyceric acid 1,3-biphosphate. This compound is desphosphorylated by a phosphoglycerate kinase resulting in a 3-phosphoglyceric acid.This compound in turn can either react with a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase or a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase resulting in a 2-phospho-D-glyceric acid. This compound interacts with an enolase resulting in a phosphoenolpyruvic acid and water. Phosphoenolpyruvic acid can react either through a AMP driven phosphoenoylpyruvate synthase or a ADP driven pyruvate kinase protein complex resulting in a pyruvic acid. Pyruvic acid reacts with CoA through a NAD driven pyruvate dehydrogenase complex resulting in a carbon dioxide and a Acetyl-CoA which gets incorporated into the TCA cycle pathway.</description>
      <pathwhiz_id>PW000916</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>glycerol metabolism IV (glycerophosphoglycerol)</name>
      <description>Glycerol metabolism starts with glycerol is introduced into the cytoplasm through a glycerol channel GlpF Glycerol is then phosphorylated through an ATP mediated glycerol kinase resulting in a Glycerol 3-phosphate. This compound can also be obtained through glycerophosphoglycerol reacting with water through a glycerophosphoryl diester phosphodiesterase producing a benzyl alcohol, a hydrogen ion and a glycerol 3-phosphate or the campound can be introduced into the cytoplasm through a glycerol-3-phosphate:phosphate antiporter. Glycerol 3-phosphate is then metabolized into a dihydroxyacetone phosphate in both aerobic or anaerobic conditions. In anaerobic conditions the metabolism is done through the reaction of glycerol 3-phosphate with a menaquinone mediated by a glycerol-3-phosphate dehydrogenase protein complex. In aerobic conditions, the metabolism is done through the reaction of glycerol 3-phosphate with ubiquinone mediated by a glycerol-3-phosphate dehydrogenase [NAD(P]+]. Dihydroxyacetone phosphate is then introduced into the fructose metabolism by turning a dihydroxyacetone into an isomer through a triosephosphate isomerase resulting in a D-glyceraldehyde 3-phosphate which in turn reacts with a phosphate through a NAD dependent Glyceraldehyde 3-phosphate dehydrogenase resulting in a glyceric acid 1,3-biphosphate. This compound is desphosphorylated by a phosphoglycerate kinase resulting in a 3-phosphoglyceric acid.This compound in turn can either react with a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase or a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase resulting in a 2-phospho-D-glyceric acid. This compound interacts with an enolase resulting in a phosphoenolpyruvic acid and water. Phosphoenolpyruvic acid can react either through a AMP driven phosphoenoylpyruvate synthase or a ADP driven pyruvate kinase protein complex resulting in a pyruvic acid. Pyruvic acid reacts with CoA through a NAD driven pyruvate dehydrogenase complex resulting in a carbon dioxide and a Acetyl-CoA which gets incorporated into the TCA cycle pathway.</description>
      <pathwhiz_id>PW000917</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>glycerol metabolism V (glycerophosphoserine)</name>
      <description>Glycerol metabolism starts with glycerol is introduced into the cytoplasm through a glycerol channel GlpF Glycerol is then phosphorylated through an ATP mediated glycerol kinase resulting in a Glycerol 3-phosphate. This compound can also be obtained through glycerophosphoserine reacting with water through a glycerophosphoryl diester phosphodiesterase producing a benzyl alcohol, a hydrogen ion and a glycerol 3-phosphate or the campound can be introduced into the cytoplasm through a glycerol-3-phosphate:phosphate antiporter. Glycerol 3-phosphate is then metabolized into a dihydroxyacetone phosphate in both aerobic or anaerobic conditions. In anaerobic conditions the metabolism is done through the reaction of glycerol 3-phosphate with a menaquinone mediated by a glycerol-3-phosphate dehydrogenase protein complex. In aerobic conditions, the metabolism is done through the reaction of glycerol 3-phosphate with ubiquinone mediated by a glycerol-3-phosphate dehydrogenase [NAD(P]+]. Dihydroxyacetone phosphate is then introduced into the fructose metabolism by turning a dihydroxyacetone into an isomer through a triosephosphate isomerase resulting in a D-glyceraldehyde 3-phosphate which in turn reacts with a phosphate through a NAD dependent Glyceraldehyde 3-phosphate dehydrogenase resulting in a glyceric acid 1,3-biphosphate. This compound is desphosphorylated by a phosphoglycerate kinase resulting in a 3-phosphoglyceric acid.This compound in turn can either react with a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase or a 2,3-bisphosphoglycerate-independent phosphoglycerate mutase resulting in a 2-phospho-D-glyceric acid. This compound interacts with an enolase resulting in a phosphoenolpyruvic acid and water. Phosphoenolpyruvic acid can react either through a AMP driven phosphoenoylpyruvate synthase or a ADP driven pyruvate kinase protein complex resulting in a pyruvic acid. Pyruvic acid reacts with CoA through a NAD driven pyruvate dehydrogenase complex resulting in a carbon dioxide and a Acetyl-CoA which gets incorporated into the TCA cycle pathway.</description>
      <pathwhiz_id>PW000918</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
    <pathway>
      <name>proline metabolism</name>
      <description>
The biosynthesis of L-proline in E. coli involves L-glutamic acid being phosphorylated through an ATP driven glutamate 5-kinase resulting in a L-glutamic acid 5-phosphate. This compound is then reduced through a NADPH driven gamma glutamyl phosphate reductase resulting in the release of a phosphate, a NADP and a L-glutamic gamma-semialdehyde. 
L-glutamic gamma-semialdehyde is dehydrated spontaneously, resulting in a release of water,hydrogen ion and 1-Pyrroline-5-carboxylic acid. The latter compound is reduced by an NADPH driven pyrroline-5-carboxylate reductase  which is subsequently reduced to L-proline. L-proline works as a repressor of the pyrroline-5-carboxylate reductase enzyme and glutamate 5-kinase.

 In E. coli, the biosynthesis of L-proline from L-glutamate is governed by three genetic loci namely proB, proA and proC. The first reaction in the pathway is catalyzed by γ-glutamyl kinase, encoded by proB . The second reaction, NADPH-dependent reduction of γ-glutamyl phosphate to glutamate-5-semialdehyde, in the pathway is catalyzed by glutamate-5-semialdehyde dehydrogenase, encoded by proA . These two enzymes aggregate into a multimeric bi-functional enzyme complex known as γ-glutamyl kinase-GP-reductase multienzyme complex. It is believed that the complex formation serves to protect the highly labile glutamyl phosphate from the hostile nucleophilic and aqueous environment found in the cell . The final step in the pathway, the reduction of pyrroline 5-carboxylate to L-proline, is catalyzed by an NADPH-dependent pyrroline-5-carboxylate reductase encoded by proC .
 
Proline is  metabolized by being converted back to L-glutamate, which is further degraded to α-ketoglutarate, an intermediate of the TCA cycle. Curiously, L-glutamate, the obligate intermediate of the proline degradation pathway, cannot itself serve as a total source of carbon and energy for E. coli, because glutamate transport supplies exogenous glutamate at an inadequate rate.
The proces by which proline is turned into L-glutamate starts with L-proline interacting with ubiquinone through a bifunctional protein putA resulting in an ubiquinol, a hydrogen ion and a 1-pyrroline-5-carboxylic acid. The latter compound is then hydrated spontaneously resulting in a L-glutamic gamma-semialdehyde. This compound is then processed by interacting with water through an NAD driven bifunctional protein putA resulting in a hydrogen ion, NADH and L-glutamic acid.</description>
      <pathwhiz_id>PW000794</pathwhiz_id>
      <kegg_map_id/>
      <subject>Metabolic</subject>
    </pathway>
  </pathways>
  <spectra>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>2429</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>133542</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>141276</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>26339</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>26340</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>26341</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>32897</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>32898</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>32899</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2698674</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2698675</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2698676</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2983178</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2983179</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2983180</spectrum_id>
    </spectrum>
  </spectra>
  <hmdb_id>HMDB02012</hmdb_id>
  <pubchem_compound_id>4462</pubchem_compound_id>
  <chemspider_id>4307</chemspider_id>
  <kegg_id>C00399</kegg_id>
  <chebi_id>16389</chebi_id>
  <biocyc_id/>
  <het_id>UQ1</het_id>
  <wikipidia>Ubiquinone</wikipidia>
  <foodb_id/>
  <general_references>
    <reference>
      <reference_text>Winder, C. L., Dunn, W. B., Schuler, S., Broadhurst, D., Jarvis, R., Stephens, G. M., Goodacre, R. (2008). "Global metabolic profiling of Escherichia coli cultures: an evaluation of methods for quenching and extraction of intracellular metabolites." Anal Chem 80:2939-2948.</reference_text>
      <pubmed_id>18331064</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pastore A, Giovamberardino GD, Bertini E, Tozzi G, Gaeta LM, Federici G, Piemonte F: Simultaneous determination of ubiquinol and ubiquinone in skeletal muscle of pediatric patients. Anal Biochem. 2005 Jul 15;342(2):352-5. Epub 2005 Mar 7.</reference_text>
      <pubmed_id>15989930</pubmed_id>
    </reference>
    <reference>
      <reference_text>Karlsson J, Lin L, Gunnes S, Sylven C, Astrom H: Muscle ubiquinone in male effort angina patients.  Mol Cell Biochem. 1996 Mar 23;156(2):173-8.</reference_text>
      <pubmed_id>9095475</pubmed_id>
    </reference>
    <reference>
      <reference_text>Passi S, Stancato A, Aleo E, Dmitrieva A, Littarru GP: Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors. 2003;18(1-4):113-24.</reference_text>
      <pubmed_id>14695926</pubmed_id>
    </reference>
    <reference>
      <reference_text>Karlsson J, Lin L, Sylven C, Jansson E: Muscle ubiquinone in healthy physically active males.  Mol Cell Biochem. 1996 Mar 23;156(2):169-72.</reference_text>
      <pubmed_id>9095474</pubmed_id>
    </reference>
    <reference>
      <reference_text>Laaksonen R, Jokelainen K, Sahi T, Tikkanen MJ, Himberg JJ: Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin Pharmacol Ther. 1995 Jan;57(1):62-6.</reference_text>
      <pubmed_id>7828383</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhang Y, Eriksson M, Dallner G, Appelkvist EL: Analysis of ubiquinone and tocopherol levels in normal and hyperlipidemic human plasma. Lipids. 1998 Aug;33(8):811-5.</reference_text>
      <pubmed_id>9727612</pubmed_id>
    </reference>
    <reference>
      <reference_text>Edlund C, Soderberg M, Kristensson K, Dallner G: Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's disease. Biochem Cell Biol. 1992 Jun;70(6):422-8.</reference_text>
      <pubmed_id>1449707</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elmberger PG, Kalen A, Brunk UT, Dallner G: Discharge of newly-synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile. Lipids. 1989 Nov;24(11):919-30.</reference_text>
      <pubmed_id>2615561</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yamashita S, Yamamoto Y: Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem. 1997 Jul 15;250(1):66-73.</reference_text>
      <pubmed_id>9234900</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mancini A, Conte G, Milardi D, De Marinis L, Littarru GP: Relationship between sperm cell ubiquinone and seminal parameters in subjects with and without varicocele. Andrologia. 1998 Feb-Mar;30(1):1-4.</reference_text>
      <pubmed_id>9567163</pubmed_id>
    </reference>
  </general_references>
  <synthesis_reference>Naruta, Yoshinori; Maruyama, Kazuhiro. . Ubiquinone-1. Organic Syntheses (1993), 71 125-32. </synthesis_reference>
  <msds_url/>
  <enzymes>
    <enzyme>
      <name>Pyruvate dehydrogenase [cytochrome]</name>
      <uniprot_id>P07003</uniprot_id>
      <uniprot_name>POXB_ECOLI</uniprot_name>
      <gene_name>poxB</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P07003.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Succinate dehydrogenase iron-sulfur subunit</name>
      <uniprot_id>P07014</uniprot_id>
      <uniprot_name>DHSB_ECOLI</uniprot_name>
      <gene_name>sdhB</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P07014.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Bifunctional protein putA</name>
      <uniprot_id>P09546</uniprot_id>
      <uniprot_name>PUTA_ECOLI</uniprot_name>
      <gene_name>putA</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P09546.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Glycerol-3-phosphate dehydrogenase [NAD(P)+]</name>
      <uniprot_id>P0A6S7</uniprot_id>
      <uniprot_name>GPDA_ECOLI</uniprot_name>
      <gene_name>gpsA</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0A6S7.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Dihydroorotate dehydrogenase</name>
      <uniprot_id>P0A7E1</uniprot_id>
      <uniprot_name>PYRD_ECOLI</uniprot_name>
      <gene_name>pyrD</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0A7E1.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Succinate dehydrogenase flavoprotein subunit</name>
      <uniprot_id>P0AC41</uniprot_id>
      <uniprot_name>DHSA_ECOLI</uniprot_name>
      <gene_name>sdhA</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AC41.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Succinate dehydrogenase hydrophobic membrane anchor subunit</name>
      <uniprot_id>P0AC44</uniprot_id>
      <uniprot_name>DHSD_ECOLI</uniprot_name>
      <gene_name>sdhD</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AC44.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit A</name>
      <uniprot_id>P0AFC3</uniprot_id>
      <uniprot_name>NUOA_ECOLI</uniprot_name>
      <gene_name>nuoA</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFC3.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit B</name>
      <uniprot_id>P0AFC7</uniprot_id>
      <uniprot_name>NUOB_ECOLI</uniprot_name>
      <gene_name>nuoB</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFC7.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit E</name>
      <uniprot_id>P0AFD1</uniprot_id>
      <uniprot_name>NUOE_ECOLI</uniprot_name>
      <gene_name>nuoE</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFD1.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit H</name>
      <uniprot_id>P0AFD4</uniprot_id>
      <uniprot_name>NUOH_ECOLI</uniprot_name>
      <gene_name>nuoH</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFD4.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit I</name>
      <uniprot_id>P0AFD6</uniprot_id>
      <uniprot_name>NUOI_ECOLI</uniprot_name>
      <gene_name>nuoI</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFD6.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit J</name>
      <uniprot_id>P0AFE0</uniprot_id>
      <uniprot_name>NUOJ_ECOLI</uniprot_name>
      <gene_name>nuoJ</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFE0.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit K</name>
      <uniprot_id>P0AFE4</uniprot_id>
      <uniprot_name>NUOK_ECOLI</uniprot_name>
      <gene_name>nuoK</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFE4.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit M</name>
      <uniprot_id>P0AFE8</uniprot_id>
      <uniprot_name>NUOM_ECOLI</uniprot_name>
      <gene_name>nuoM</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFE8.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit N</name>
      <uniprot_id>P0AFF0</uniprot_id>
      <uniprot_name>NUON_ECOLI</uniprot_name>
      <gene_name>nuoN</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0AFF0.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Quinoprotein glucose dehydrogenase</name>
      <uniprot_id>P15877</uniprot_id>
      <uniprot_name>DHG_ECOLI</uniprot_name>
      <gene_name>gcd</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P15877.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>3-demethylubiquinone-9 3-methyltransferase</name>
      <uniprot_id>P17993</uniprot_id>
      <uniprot_name>UBIG_ECOLI</uniprot_name>
      <gene_name>ubiG</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P17993.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit F</name>
      <uniprot_id>P31979</uniprot_id>
      <uniprot_name>NUOF_ECOLI</uniprot_name>
      <gene_name>nuoF</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P31979.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit C/D</name>
      <uniprot_id>P33599</uniprot_id>
      <uniprot_name>NUOCD_ECOLI</uniprot_name>
      <gene_name>nuoC</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P33599.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit G</name>
      <uniprot_id>P33602</uniprot_id>
      <uniprot_name>NUOG_ECOLI</uniprot_name>
      <gene_name>nuoG</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P33602.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>NADH-quinone oxidoreductase subunit L</name>
      <uniprot_id>P33607</uniprot_id>
      <uniprot_name>NUOL_ECOLI</uniprot_name>
      <gene_name>nuoL</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P33607.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Succinate dehydrogenase cytochrome b556 subunit</name>
      <uniprot_id>P69054</uniprot_id>
      <uniprot_name>DHSC_ECOLI</uniprot_name>
      <gene_name>sdhC</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P69054.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Ubiquinol oxidase subunit 2</name>
      <uniprot_id>P0ABJ1</uniprot_id>
      <uniprot_name>CYOA_ECOLI</uniprot_name>
      <gene_name>cyoA</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0ABJ1.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome o ubiquinol oxidase protein cyoD</name>
      <uniprot_id>P0ABJ6</uniprot_id>
      <uniprot_name>CYOD_ECOLI</uniprot_name>
      <gene_name>cyoD</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0ABJ6.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome bd-II oxidase subunit 2</name>
      <uniprot_id>P26458</uniprot_id>
      <uniprot_name>APPB_ECOLI</uniprot_name>
      <gene_name>appB</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P26458.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome bd-II oxidase subunit 1</name>
      <uniprot_id>P26459</uniprot_id>
      <uniprot_name>APPC_ECOLI</uniprot_name>
      <gene_name>appC</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P26459.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome d ubiquinol oxidase subunit 2</name>
      <uniprot_id>P0ABK2</uniprot_id>
      <uniprot_name>CYDB_ECOLI</uniprot_name>
      <gene_name>cydB</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0ABK2.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Ubiquinol oxidase subunit 1</name>
      <uniprot_id>P0ABI8</uniprot_id>
      <uniprot_name>CYOB_ECOLI</uniprot_name>
      <gene_name>cyoB</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0ABI8.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome d ubiquinol oxidase subunit 1</name>
      <uniprot_id>P0ABJ9</uniprot_id>
      <uniprot_name>CYDA_ECOLI</uniprot_name>
      <gene_name>cydA</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0ABJ9.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome o ubiquinol oxidase subunit 3</name>
      <uniprot_id>P0ABJ3</uniprot_id>
      <uniprot_name>CYOC_ECOLI</uniprot_name>
      <gene_name>cyoC</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P0ABJ3.xml</protein_url>
    </enzyme>
    <enzyme>
      <name>Cytochrome bd-I ubiquinol oxidase subunit X</name>
      <uniprot_id>P56100</uniprot_id>
      <uniprot_name>CYDX_ECOLI</uniprot_name>
      <gene_name>cydX</gene_name>
      <protein_url>http://ecmdb.ca/proteins/P56100.xml</protein_url>
    </enzyme>
  </enzymes>
  <transporters>
  </transporters>
  <reactions>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id>R02166</kegg_reaction_id>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Pyruvic acid + Ubiquinone-1 + Water &lt;&gt; Acetic acid + Ubiquinol-8 + Carbon dioxide</reaction_text>
    <kegg_reaction_id>R03145</kegg_reaction_id>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>D-Glucose + Ubiquinone-1 &lt;&gt; Gluconolactone + Ubiquinol-8</reaction_text>
    <kegg_reaction_id>R06620</kegg_reaction_id>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>2-Polyprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone + S-Adenosylmethionine &lt;&gt; Ubiquinone-1 + S-Adenosylhomocysteine</reaction_text>
    <kegg_reaction_id>R08781</kegg_reaction_id>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>NADH + Ubiquinone-1 &lt;&gt; NAD + Ubiquinol-8</reaction_text>
    <kegg_reaction_id>R02163 </kegg_reaction_id>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Succinic acid + Ubiquinone-1 &gt; Ubiquinol-1 + Fumaric acid</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_R002619</pw_reaction_id>
    <reaction_text>L-Proline + Ubiquinone-1 + L-Proline &gt; Hydrogen ion + Ubiquinol-1 + 1-Pyrroline-5-carboxylic acid + L-D-1-Pyrroline-5-carboxylic acid</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_R002720</pw_reaction_id>
    <reaction_text>Glycerol 3-phosphate + Ubiquinone-1 &gt; Dihydroxyacetone phosphate + Ubiquinol-1</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_R003441</pw_reaction_id>
    <reaction_text>4,5-Dihydroorotic acid + Ubiquinone-1 + 4,5-Dihydroorotic acid &gt; Ubiquinol-1 + Orotic acid</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_R003528</pw_reaction_id>
    <reaction_text>2 Ubiquinol-1 + Oxygen + 4 Hydrogen ion &gt;2 Ubiquinone-1 +2 Water +4 Hydrogen ion</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_RCT000140</pw_reaction_id>
    <reaction_text>Oxygen + 8 Hydrogen ion + 2 Ubiquinol-1 &gt;2 Water +8 Hydrogen ion +2 Ubiquinone-1</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_RCT000142</pw_reaction_id>
    <reaction_text>NADH + 5 Hydrogen ion + Ubiquinone-1 &gt; Hydrogen ion + NAD + Ubiquinol-1</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id>PW_RCT000143</pw_reaction_id>
    <reaction_text>D-Glucose + Ubiquinone-1 &lt;&gt; Gluconolactone + Ubiquinol-8</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>NADH + Ubiquinone-1 &lt;&gt; NAD + Ubiquinol-8</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Pyruvic acid + Ubiquinone-1 + Water &lt;&gt; Acetic acid + Ubiquinol-8 + Carbon dioxide</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>D-Glucose + Ubiquinone-1 &lt;&gt; Gluconolactone + Ubiquinol-8</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Ubiquinol-8 + Acceptor &lt;&gt; Ubiquinone-1 + Reduced acceptor</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
    <reaction_text>Pyruvic acid + Ubiquinone-1 + Water &lt;&gt; Acetic acid + Ubiquinol-8 + Carbon dioxide</reaction_text>
    <kegg_reaction_id/>
    <ecocyc_id/>
    <pw_reaction_id/>
  </reactions>
  <concentrations>
  </concentrations>
</compound>
